GHO Capital

Healthcare and life sciences private equity investment firm
Healthcare & Life Sciences PEF
Tier I

Overview

GHO Capital is a specialist healthcare investment firm focused on building businesses across healthcare services, pharmaceutical and life sciences services, medtech, diagnostics, and related healthcare markets. Its investment model combines sector research, operating resources, and transatlantic development.

The firm has grown into one of Europe’s largest dedicated healthcare investment platforms. Its portfolio reflects the importance of outsourced pharmaceutical infrastructure, medical products, patient services, and healthcare businesses that can scale across national markets. Within The Economy Wiki, the firm is connected to the Healthcare & Life Sciences PEF market category.

Firm facts

Institution	GHO Capital
Type	Healthcare and life sciences private equity investment firm
Headquarters	London, United Kingdom
Founded	2014
Primary ranking focus	Healthcare & Life Sciences PEF
Highest 2026 tier	Tier I

Contents

Activities and investment capabilities
Strategy and transaction coverage
Market position
Competitive context
Leadership and governance
Corporate and public information
Ranking recognition
Related Economy analysis
Related institutions and subjects
Sources

Activities and investment capabilities

In May 2026, GHO and CBC Group announced an intended combination that would create a healthcare-focused investment platform with more than $21 billion in combined assets under management. The transaction is expected to close after customary approvals, so GHO remains separately evaluated in this edition.

Healthcare investing

Equity investment across healthcare services, products and technology.

Life sciences exposure

Capital for pharmaceutical, biotechnology, medtech and outsourced-service platforms.

Sector value creation

Support informed by regulation, reimbursement, clinical workflows and market access.

Strategy and transaction coverage

Strategy and sector coverage

Healthcare services; life sciences; pharmaceuticals; medtech; diagnostics; healthcare IT

Transaction and ownership contexts

Buyouts; growth investments; recapitalizations; platform formation; add-on acquisitions

Market position

GHO Capital fits Tier I because it combines dedicated healthcare specialization, substantial institutional scale, transatlantic reach, and a clear record of supporting internationally oriented healthcare companies.

GHO Capital is assessed within the Healthcare & Life Sciences PEF framework. For wider market context, see The Mid-Market Advantage in Healthcare Private Equity.

Competitive context

GHO Capital is recognized Tier I in Top 30 Healthcare & Life Sciences PEF 2026. The ranking compares firms by institutional relevance, specialist capability, investment activity, operating depth and market positioning. Comparable-firm links below support navigation and do not imply that every institution competes for every transaction or asset.

Leadership and governance

Leadership, investment-committee composition and operating resources may change over time. Current information should be confirmed through GHO Capital’s official website.

Leadership area	Current source
Investment and operating leadership	Current team and governance information

Corporate and public information

This profile refers to GHO Capital as the public-facing investment organization. Individual funds, management companies, advisers and regulated entities may use separate legal names across jurisdictions.

Corporate and disclosure information

Organization	GHO Capital
Headquarters	London, United Kingdom
Public website	ghocapital.com
Profile basis	Public institutional information and Capital Ranking editorial research